TY - JOUR
T1 - Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery
T2 - Results from a Department of Veterans Affairs Cooperative Study
AU - Goldman, Steven
AU - Zadina, Karen
AU - Moritz, Thomas
AU - Ovitt, Theron
AU - Sethi, Gulshan
AU - Copeland, Jack G.
AU - Thottapurathu, Lizy
AU - Krasnicka, Barbara
AU - Ellis, Nancy
AU - Anderson, Robert J.
AU - Henderson, William
N1 - Funding Information:
Supported by the Cooperative Studies Program of the Department of Veterans Affairs Research and Development Service, Washington, DC.
PY - 2004/12/7
Y1 - 2004/12/7
N2 - This study defined long-term patency of saphenous vein grafts (SVG) and internal mammary artery (IMA) grafts. This VA Cooperative Studies Trial defined 10-year SVG patency in 1,074 patients and left IMA patency in 457 patients undergoing coronary artery bypass grafting (CABG). Patients underwent cardiac catheterizations at 1 week and 1, 3, 6, and 10 years after CABG. Patency at 10 years was 61% for SVGs compared with 85% for IMA grafts (p < 0.001). If a SVG or IMA graft was patent at 1 week, that graft had a 68% and 88% chance, respectively, of being patent at 10 years. The SVG patency to the left anterior descending artery (LAD) (69%) was better (p < 0.001) than to the right coronary artery (56%), or circumflex (58%). Recipient vessel size was a significant predictor of graft patency, in vessels >2.0 mm in diameter SVG patency was 88% versus 55% in vessels ≤2.0 mm (p < 0.001). Other positive significant predictors of graft patency were use of aspirin after bypass, older age, lower serum cholesterol, and lowest Canadian Functional Class (p < 0.001 to 0.058). The 10-year patency of IMA grafts is better than SVGs. The 10-year patency for SVGs is better and the 10-year patency for IMA grafts is worse than expected. The 10-year patency of SVGs to the LAD is better than that to the right or circumflex. The best long-term predictors of SVG graft patency are grafting into the LAD and grafting into a vessel that is >2.0 mm in diameter.
AB - This study defined long-term patency of saphenous vein grafts (SVG) and internal mammary artery (IMA) grafts. This VA Cooperative Studies Trial defined 10-year SVG patency in 1,074 patients and left IMA patency in 457 patients undergoing coronary artery bypass grafting (CABG). Patients underwent cardiac catheterizations at 1 week and 1, 3, 6, and 10 years after CABG. Patency at 10 years was 61% for SVGs compared with 85% for IMA grafts (p < 0.001). If a SVG or IMA graft was patent at 1 week, that graft had a 68% and 88% chance, respectively, of being patent at 10 years. The SVG patency to the left anterior descending artery (LAD) (69%) was better (p < 0.001) than to the right coronary artery (56%), or circumflex (58%). Recipient vessel size was a significant predictor of graft patency, in vessels >2.0 mm in diameter SVG patency was 88% versus 55% in vessels ≤2.0 mm (p < 0.001). Other positive significant predictors of graft patency were use of aspirin after bypass, older age, lower serum cholesterol, and lowest Canadian Functional Class (p < 0.001 to 0.058). The 10-year patency of IMA grafts is better than SVGs. The 10-year patency for SVGs is better and the 10-year patency for IMA grafts is worse than expected. The 10-year patency of SVGs to the LAD is better than that to the right or circumflex. The best long-term predictors of SVG graft patency are grafting into the LAD and grafting into a vessel that is >2.0 mm in diameter.
UR - http://www.scopus.com/inward/record.url?scp=9644291513&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=9644291513&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2004.08.064
DO - 10.1016/j.jacc.2004.08.064
M3 - Article
C2 - 15582312
AN - SCOPUS:9644291513
SN - 0735-1097
VL - 44
SP - 2149
EP - 2156
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 11
ER -